levamisole has been researched along with diphosphoric acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fonseca-de-Souza, AL; Freitas-Mesquita, AL; Meyer-Fernandes, JR | 1 |
| Hamano, H; Hiratsuka, S; Iwasaki, N; Ota, M; Sato, D; Shimizu, T; Takahata, M | 1 |
| Villa-Bellosta, R | 1 |
3 other study(ies) available for levamisole and diphosphoric acid
| Article | Year |
|---|---|
Leishmania amazonensis: characterization of an ecto-pyrophosphatase activity.
Topics: Animals; Calcium Chloride; Cell Membrane; Chlorides; Cricetinae; Diphosphates; Dose-Response Relationship, Drug; Humans; Hydrogen-Ion Concentration; Hydrolysis; Leishmania mexicana; Leishmaniasis, Diffuse Cutaneous; Levamisole; Magnesium Chloride; Manganese Compounds; Pyrophosphatases; Sodium Fluoride; Tartrates; Vanadates | 2014 |
Drug therapy targeting pyrophosphate slows the ossification of spinal ligaments in twy mice.
Topics: Animals; Antirheumatic Agents; Benzoates; Bone Remodeling; Diphosphates; Drug Evaluation, Preclinical; Drug Therapy, Combination; Levamisole; Male; Mice; Molecular Targeted Therapy; Naphthols; Ossification of Posterior Longitudinal Ligament; Random Allocation | 2018 |
ATP-based therapy prevents vascular calcification and extends longevity in a mouse model of Hutchinson-Gilford progeria syndrome.
Topics: Adenosine Triphosphate; Alkaline Phosphatase; Animals; Antigens, CD; Aortic Diseases; Apyrase; Calcinosis; Diphosphates; Disease Models, Animal; Gene Knock-In Techniques; Humans; Lamin Type A; Levamisole; Longevity; Male; Mice; Mice, Transgenic; Myocytes, Smooth Muscle; Phosphoric Diester Hydrolases; Progeria; Pyrophosphatases; Real-Time Polymerase Chain Reaction; RNA Interference; RNA, Small Interfering | 2019 |